Massive loss masks order strength; recovery unproven

Q1 revenue only ₹85.3 Cr; even at ₹50-55 Cr recovery target, would reach ₹135-140 Cr—still below prior Q1 ₹102.4 Cr

Order book exists but conversion unproven; company lost ₹17.6 Cr in Q1 despite ₹699 Cr backlog

No quantified revenue or unit sales disclosed; product launch claimed last quarter but zero financial impact visible

Q1 EBITDA -₹14.9 Cr (-17.5% margin); requires 34pp swing from -17.5% to +14-16%—structural gap unaddressed

Supply chain stabilizing as of August; but underlying operational challenges remain unquantified

Prior: 14-16% EBITDA margin target. Current: same target but deferred to ₹850 Cr revenue (2-3 years away). Q1 margin -17.5%—34pp gap.

FY27 order intake ₹1,000 Cr maintained; achieved ₹200 Cr YTD. Equivalent to prior guidance, no change.

Prior call: strong growth from S&P/exports. Current: growth 'subject to execution challenges'; only 80-85% order book conversion assumed.

Prior: supply chain headwinds acknowledged as 'short-term.' Current: explicitly stating 'challenges in execution, a bit of the industry' and margin pressure from talent investments.

₹15 Cr from trading segment, ₹42-43 Cr from manufacturing (S&P/order deferrals) = ₹50-55 Cr total impact

Supply chain stabilizing; expect growth phase but subject to 6-week stabilization window; hedged with 'some challenges' in execution

80-85% order book conversion = growth; but qualified with 'challenges in execution.' Deflected on exact growth %.

EUR600K order, metal slag industry, delivery Q3, export margins better than India. Withheld exact margin % ('too early to tell').

₹1,000 Cr order intake target overall; ₹200 Cr already achieved; large orders in pipeline to convert next 3-4 months.

FY27 margins depressed due to investments; 14-16% target once revenue crosses ₹850 Cr (2 years); 15-20% growth next 2 years, 20-25% with EBITDA 12-16% in 2-3 years.

Less than 2% stake; USD575K infused. Primarily licensing arrangement, exclusive India/UAE rights.

Dehumidification (data centres, battery manufacturing) and AWG both huge; no numbers now, will share Q2. Deflected on specifics.

Offered offline discussion; stated alcohol beverage, steel, pharma, chemical, solar as major segments.

Steel industry pursuing ZLD due to water constraints. Management demonstrated waste-pickle liquor solution, expect to convert to order in 2 months. Strong market position vs competition.

Initially studied market; now offering innovative, energy-efficient solutions vs incumbent installs. Made inroads with couple of larger players; converting retrofit/efficiency deals.

Partnering with US firm with Micron collaboration. Targeting membrane replacement first, then project segment. Path-to-scale via partners.

Customers worry about water, energy, carbon footprint together. Heat exchanger born from evaporator R&D need. Solutions connected; same customer base; solve 2 problems.

Carbon potentially larger than water. Government mandates issued (steel, fertilizer, cement). Implementation learning curve 3-5 years. Biological route chosen. Will be large in 3-5 years.

Ion Exchange, Thermax, Arvind Envisol, Praj Engineering, Permionics, Hyper Filtration. Company just below Ion Exchange in market share (prior survey 2 yrs ago).

Water recycling and dehumidification both applicable. Sales teams in talks with large players. WaHa cooling + water solutions for data centre cooling. Significant product opportunity on both sides.

Large orders in pipeline (domestic + international) expected to convert over next 3-4 months. Contingent on sustained market demand.

₹699 Cr order book; conversion dependent on execution stability. Management acknowledges 'challenges in execution'; Q1 miss illustrates execution risk.

Contingent on 6-week stabilization window (as of August). Explicitly qualified: 'subject to things playing out over next six weeks.'

Deferred to revenue ₹850 Cr+ (2-3 years out). Near-term margins depressed by talent/execution investments. Q1 EBITDA margin -17.5%.

Assumes successful order book conversion and margin recovery. No detail on margin bridge from -17.5% to +12-16%.

Management transparent that FY27 will remain challenged; cited cost inflation (talent, execution) and supply chain instability.

Q1 net loss ₹17.6 Cr despite ₹699 Cr order book suggests significant project costing, scheduling, or resource issues. Large steel orders (₹1,260 Cr) require flawless execution.

Middle East conflict caused ₹50-55 Cr revenue loss in Q1. Freight/spare parts normalized by July but remaining upside-downside risks to Q2+ execution.

Q1 NPM -19.1% vs target 14-16% EBITDA represents 30-35pp gap. Driven by revenue loss, fixed cost deleverage, and talent/execution investments. Recovery timeline 2-3 years uncertain.

H-Xtreme claimed to be 'gaining meaningful traction' but zero revenue recognized in Q1; WaHa partnership only ₹48 Lakh invested, no revenue model detailed; Europe ZLD is first-time execution. Cannibalization risk if these replace core S&P revenue.

Steel sector order book significant (₹1,260 Cr from largest steel manufacturer); pharma, chemical 'strong' (unquantified). Sector cycle downturn or major customer postponement could crater order intake/conversion.